Meditecha - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 91,733 | 220,008 | 389,590 | 869,505 | 934,135 | 1,004,302 | 1,189,107 | 480,482 |
| Profit before tax | 883 | 15,763 | -905 | 76,934 | 28,062 | 38,403 | - | - |
| Net profit | 870 | 14,771 | -2,945 | 67,588 | 21,369 | 32,263 | 18,301 | -82,299 |
| Equity | 33,958 | 33,564 | 30,619 | 95,715 | 123,777 | 156,040 | 171,340 | 121,449 |
| Liabilities | 60,346 | 176,131 | 210,925 | 209,495 | 166,565 | 363,275 | 294,701 | 275,952 |
| Non-current assets | 29,180 | 31,173 | 71,293 | 56,423 | 45,464 | 28,721 | 15,921 | 7,983 |
| Current assets | 65,124 | 178,522 | 169,081 | 247,506 | 242,452 | 490,594 | 449,578 | 389,418 |
| Total assets | 94,304 | 209,695 | 240,374 | 303,929 | 287,916 | 519,315 | 465,499 | 397,401 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 82,277 | 65,531 | 617 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +190.0% | +139.8% | +77.1% | +123.2% | +7.4% | +7.5% | +18.4% | -59.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.9% | 7.0% | -1.2% | 22.2% | 7.4% | 6.2% | 3.9% | -20.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 2.6% | 44.0% | -9.6% | 70.6% | 17.3% | 20.7% | 10.7% | -67.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.9% | 6.7% | -0.8% | 7.8% | 2.3% | 3.2% | 1.5% | -17.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.0% | 7.2% | -0.2% | 8.8% | 3.0% | 3.8% | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.8 | 5.2 | 6.9 | 2.2 | 1.3 | 2.3 | 1.7 | 2.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 18,979 | 73,336 | 123,027 | 260,854 | 233,534 | 446,356 | 419,690 | 160,161 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Meditecha - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-10-23 | 2025-11-04 | 0.07 |
| 2025-09-16 | 2025-09-21 | 1196.72 |
| 2025-09-07 | 2025-09-15 | 9.90 |
| 2025-08-31 | 2025-09-03 | 9.90 |
| 2025-08-19 | 2025-08-29 | 9.90 |
| 2025-07-24 | 2025-08-05 | 9.90 |
| 2025-05-16 | 2025-05-28 | 1144.46 |
| 2025-05-04 | 2025-05-05 | 1154.46 |
| 2025-04-16 | 2025-04-30 | 1154.46 |
| 2022-08-23 | 2022-08-29 | 26.49 |
| 2022-02-17 | 2022-02-22 | 272.33 |
Meditecha - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Meditecha, UAB (code 303411878) is a Private Limited Liability Company engaged in the retail sale of other medical and orthopaedic goods. In 2025, the company generated €480.5K in revenue, down 59.6% year on year and 52.2% over two years. The decline in turnover was accompanied by a sharp deterioration in profitability: net profit fell to a loss of €82.3K, compared with a profit of €18.3K in 2024 and €32.3K in 2023. Profit margin turned negative to -17.1% in 2025, after 1.5% in 2024 and 3.2% in 2023.
The balance sheet also weakened during the period. Total assets decreased to €397.4K in 2025 from €465.5K in 2024 and €519.3K in 2023. Equity stood at €121.4K, while liabilities were €276.0K, leaving an equity ratio of 30.6% and debt-to-equity of 2.27. Short-term assets accounted for most of the asset base at €389.4K, while long-term assets were €8.0K. Return on equity was -67.8% and return on assets -20.7% in 2025. Revenue per employee was €160.2K, while profit per employee was negative.
The balance sheet also weakened during the period. Total assets decreased to €397.4K in 2025 from €465.5K in 2024 and €519.3K in 2023. Equity stood at €121.4K, while liabilities were €276.0K, leaving an equity ratio of 30.6% and debt-to-equity of 2.27. Short-term assets accounted for most of the asset base at €389.4K, while long-term assets were €8.0K. Return on equity was -67.8% and return on assets -20.7% in 2025. Revenue per employee was €160.2K, while profit per employee was negative.